Is FDA Cosmetic GMP Mandatory Yet? Where the MoCRA Rule Stands in 2026

Quick Answer

Not yet. MoCRA told FDA to propose a cosmetic GMP rule by December 29, 2024 and to finalize it by December 29, 2025. FDA missed both dates, and its regulatory agenda now targets November 2027 for the proposal. Until a final rule exists, no FDA cosmetic GMP regulation applies, but the ban on adulterated cosmetics already does.

Factory decks love the phrase "FDA GMP." Many founders read it as a federal stamp of approval. For cosmetics, that stamp does not exist yet, because the rule behind it is almost two years past its first legal deadline.

This guide covers where the MoCRA GMP rule stands, what it would require once final, who the small-business exemption covers, and which documents show good manufacturing practice today.

Key Takeaways

  • FDA has no cosmetic GMP regulation in force. MoCRA required one, and both statutory deadlines have passed.
  • The latest Unified Agenda lists the proposed rule as a long-term action with a November 2027 target.
  • Once final, the rule makes GMP a legal condition: a cosmetic made under conditions that miss it counts as adulterated.
  • The small-business exemption never covers eye-area, injected, internal-use or long-wear products.
  • Today, an ISO 22716 certificate or a Korean CGMP designation shows GMP. An FDA registration number does not.

Is FDA Cosmetic GMP a Legal Requirement Today?

No. FDA has not issued a cosmetic GMP regulation, so no federal cosmetic GMP rule exists to meet or to be certified against. FDA's MoCRA page, current as of October 29, 2026, still lists GMP among the regulations MoCRA requires the agency to establish (FDA).

For GMP, that page links only two documents: a June 2023 public listening session and a draft guidance from June 2013. The draft is marked not for implementation and contains non-binding recommendations (FDA).

No rule does not mean no rules. Federal law already treats a cosmetic as adulterated if it was prepared, packed or held under insanitary conditions that could contaminate it or make it injurious to health. That is section 601(c) of the FD&C Act (21 U.S.C. 361), and FDA can act on it today.

Good manufacturing practice (GMP) is the system of written procedures and controls that keeps every batch made the same way, from raw materials to shipment. A GMP rule would turn those controls into a written federal standard.

Two Statutory Deadlines Passed Without a Proposal

MoCRA set a clear clock. Section 606 of the FD&C Act required a proposed GMP rule within two years of December 29, 2022, and a final rule within three years (21 U.S.C. 364b).

DateMilestoneStatus
December 29, 2022MoCRA signed into lawDone
June 1, 2023FDA public listening session on cosmetic GMP (FDA)Held
December 29, 2024Statutory deadline for the proposed ruleMissed
December 29, 2025Statutory deadline for the final ruleMissed
Latest Unified AgendaProposed rule listed as a long-term action (reginfo.gov)Target: November 2027

The Unified Agenda is the federal government's published list of planned rules. Its entry for this rule, RIN 0910-AJ00, is titled Good Manufacturing Practice for Cosmetic Product Facilities. It lists the stage as long-term actions and the proposal date as November 2027 (reginfo.gov).

Agenda dates are targets, so read November 2027 as a plan, not a promise. When the proposal does arrive, it opens a public comment period first. Binding dates come only with the final rule.

What Would the Rule Make Mandatory Once It Is Final?

A final rule would turn GMP into a legal condition of selling cosmetics in the US. MoCRA already wrote the consequence into the law: a cosmetic made or processed under conditions that miss the section 606 GMP requirements is adulterated (21 U.S.C. 361(f)).

The statute also sets the frame FDA has to write inside (21 U.S.C. 364b):

  • Facilities. The rule covers facilities that manufacture or process cosmetic products.
  • Standards. It has to be consistent with national and international standards, to the extent practicable and appropriate.
  • Purpose. It has to protect public health and keep cosmetic products from being adulterated.
  • Records. It can let FDA inspect the records that show GMP compliance during an inspection.
  • Smaller businesses. It has to include simplified requirements where appropriate, and it can give smaller businesses longer to comply.

MoCRA defines a facility as any establishment that manufactures or processes cosmetic products distributed in the United States (FDA). A Korean plant that makes your product for the US market fits that definition. The agenda entry names 21 CFR part 711 as the rule's planned home.

The Small-Business Exemption Has Hard Limits

MoCRA exempts certain small businesses from GMP, facility registration and product listing (FDA). The test is average gross annual US sales of cosmetic products of less than $1,000,000 over the previous three years, adjusted for inflation (21 U.S.C. 364h).

The exemption never applies to a business that makes or processes these products (FDA):

  • Products that regularly contact the mucous membrane of the eye in customary use
  • Products that are injected
  • Products intended for internal use
  • Products meant to alter appearance for more than 24 hours, where removal by the consumer is not part of normal use

The test also applies business by business. A small brand's sales do not carry over to the contract factory that makes its products, and the factory's GMP and registration status depend on its own position. The exemption covers GMP, registration and listing only, so duties such as serious adverse event reporting still apply.

"I'm Liz, I run ALTAMEET from Manhattan, NYC. A line like 'FDA GMP certified' in a factory deck is my cue to ask which document stands behind it. If you want a quick gut-check on whether Korean ODM fits your project, I'll give you 15 minutes free."

Book a free 15-min gut-check

What Proves Good Manufacturing Practice Today?

Two documents carry real weight today: an ISO 22716 certificate and a Korean CGMP designation. Neither is a US government approval, and each proves something narrower than "FDA GMP."

ISO 22716 is the international guideline for cosmetic GMP. It covers the production, control, storage and shipment of cosmetic products, and it leaves out research and development and the distribution of finished products (ISO). ISO last reviewed and confirmed the 2007 edition in 2022.

FDA's 2013 draft guidance reviewed ISO 22716 and incorporated, modified or excluded parts of it. FDA has also said it intends to withdraw or revise that draft based on the MoCRA rulemaking (FDA).

Korea runs its own program. MFDS, Korea's Ministry of Food and Drug Safety, calls it the Cosmetic Good Manufacturing Practice standard, or CGMP, and assesses the factories that apply. MFDS has described CGMP as a program it runs without making it a legal requirement (Cosmorning).

DocumentWho stands behind itWhat it showsWhat it does not show
ISO 22716 certificateAn independent certification bodyThe plant's GMP system was audited against the international guidelineUS approval, or that your batch was made under it
Korean CGMP designationMFDS, Korea's regulatorThe plant met Korea's cosmetic GMP standard when assessedA US requirement or a US approval
FDA facility registrationThe facility owner or operator, filed with FDAFDA has the plant on fileApproval, inspection results or GMP status
An "FDA GMP certified" claimNobody, for cosmeticsNothing yet, since no FDA cosmetic GMP rule existsTreat it as a question for the factory

Always match the certificate to the site. A certificate for a sister plant or an old address tells you nothing about the line that fills your product.

An FDA Registration Number Is Not a GMP Certificate

A registration number is the document most often passed off as proof of quality. FDA states that it does not issue certificates or other documents to verify facility registration or product listing. It also says a registration number does not indicate FDA approval of the facility or its products (FDA).

Registration is a filing made by the facility's owner or operator and renewed every two years from the initial registration date. It shows that FDA has the plant on file, nothing more. Our guide to proving MoCRA compliance without an FDA certificate covers what to ask for instead.

The same logic covers products. Cosmetics and their ingredients do not need FDA approval before sale, except color additives (FDA). Any "FDA approved" line on a cosmetic deserves the same question.

What Should a Founder Do While the Rule Is Pending?

Build your file as if the rule were final, because the adulteration standard already applies. Three steps cover most of the risk.

  1. Ask for the GMP document, not the slogan. Request the ISO 22716 certificate or the MFDS CGMP designation, with the issuer, scope, site address and expiry.
  2. Match registration to the plant. Confirm the FDA facility registration covers the same site that makes your product, and keep a copy in your records.
  3. Watch the rule. Check the Unified Agenda entry and FDA's MoCRA page twice a year. A proposal will come with a comment period before anything binds.

Site checks, batch records and sample review belong in a full pre-order review. Our guide to vetting a Korean ODM before the PO covers that process. Our list of delivery documents to demand at ship-out covers the paperwork that travels with each shipment.

For the wider import picture, start with our FDA guide to importing Korean skincare. New to Korean manufacturing? Our step-by-step guide to starting a K-beauty skincare brand covers the earlier decisions.

MoCRA GMP Document Checklist

Walk through the GMP documents for your own factory shortlist on a free 15-minute call.

Get the Free Checklist

Frequently Asked Questions

Does a Korean ODM need FDA approval to make cosmetics for the US?
No. Cosmetics and their ingredients do not need FDA approval before sale, except color additives. A plant that makes cosmetics for the US registers with FDA unless an exemption applies, and that registration is not an approval.

Is ISO 22716 certification required to sell cosmetics in the US?
No US law requires it today. ISO 22716 is the international guideline FDA reviewed for its 2013 draft guidance, and MoCRA tells FDA to align its rule with international standards where practicable. That makes it the closest benchmark for now.

When will FDA cosmetic GMP become mandatory?
No date is set. The latest Unified Agenda targets November 2027 for the proposed rule, and a final rule follows public comment. Compliance dates will come with the final rule, and smaller businesses can get longer to comply.

Does the small-business exemption cover a brand that uses a contract manufacturer?
It covers each business that meets the test, for its own duties. A small brand can be exempt from product listing, while the factory's GMP and registration status depend on the factory's own sales. Eye-area, injected, internal-use and long-wear products never qualify.

By Liz Song, K-beauty sourcing consultant.

Next
Next

Pimple Patches: Cosmetic, Device or OTC Drug? K-Beauty Founder Rules